S23-287 Using de novo protein design to target MHC-1 and MR-1 antigens Stanford scientists have created a de novo protein design platform that designs binding proteins that specifically target antigens in the major histocompatibility complex (MHC). Possu Huang Haotian Du Nikolaos Sgourakis Leena Mallik